BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Clinical Outcome
82 results:

  • 1. Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic.
    Chopra S; Mulani J; Mittal P; Singh M; Shinde A; Gurram L; Scaria L; Aravindakshan D; Kohle S; Rane P; Ghadi Y; Rath S; Ghosh J; Gulia S; Gupta S; Kinhikar R; Laskar S; Agarwal JP
    Brachytherapy; 2023; 22(2):125-131. PubMed ID: 36585283
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Positive
    Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
    Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: clinical outcome and prognostic factors.
    Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
    Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.
    Zeng J; Sun P; Ping Q; Jiang S; Hu Y
    PLoS One; 2022; 17(3):e0266001. PubMed ID: 35324998
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Magnetic Resonance Imaging-Guided Adaptive Brachytherapy for the Treatment of cervical cancer and its Impact on clinical outcome.
    Singhal S; Veeratterapillay J; Locks S; Morgan D; Patil R; Chamberlain HM
    Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):442-451. PubMed ID: 35123850
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Impact of Histological Subtype on Survival outcome of Patients with Stage IIB-IVA cervical cancer Who Received Definitive Radiotherapy.
    Miyahara S; Tsuji K; Shimada M; Shibuya Y; Shigeta S; Nagai T; Umezawa R; Tokunaga H; Jingu K; Yaegashi N
    Tohoku J Exp Med; 2021 Dec; 255(4):303-313. PubMed ID: 34911878
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Quality of life and long-term clinical outcome following robot-assisted radical trachelectomy.
    Ekdahl L; Crusensvärd M; Reynisson P; Lönnerfors C; Persson J
    Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():234-240. PubMed ID: 34837852
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Combination of Radiomics and Machine Learning with Diffusion-Weighted MR Imaging for clinical outcome Prognostication in cervical cancer.
    Jajodia A; Gupta A; Prosch H; Mayerhoefer M; Mitra S; Pasricha S; Mehta A; Puri S; Chaturvedi A
    Tomography; 2021 Aug; 7(3):344-357. PubMed ID: 34449713
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long-term clinical outcome and dosimetric comparison of tandem and ring versus tandem and ovoids intracavitary application in cervical cancer.
    Atasever Akkas E; Altundag MB
    J BUON; 2021; 26(3):698-706. PubMed ID: 34268923
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis.
    Jablonska PA; Cambeiro M; Gimeno M; Aramendía JM; Mínguez JA; Alcázar JL; Aristu JJ; Calvo FA; Martínez-Monge R
    Clin Transl Oncol; 2021 Sep; 23(9):1934-1941. PubMed ID: 33835408
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Treatment outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for cervical cancer.
    Mukai Y; Minagawa Y; Inoue H; Sato A; Matsui K; Fukuda T; Onuma K; Hongo H; Shirata R; Nagata H; Hashimoto H; Inoue T; Hata M; Omura M
    In Vivo; 2020; 34(6):3387-3398. PubMed ID: 33144446
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Spinal meningiomas: Treatment outcome and long-term follow-up.
    Kwee LE; Harhangi BS; Ponne GA; Kros JM; Dirven CMF; Dammers R
    Clin Neurol Neurosurg; 2020 Nov; 198():106238. PubMed ID: 33096449
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
    Yoshimoto Y; Sasaki Y; Murata K; Noda SE; Miyasaka Y; Hamamoto J; Furuya M; Hirato J; Suzuki Y; Ohno T; Tokino T; Oike T; Nakano T
    Gynecol Oncol; 2020 Nov; 159(2):546-553. PubMed ID: 32951893
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Interdigitated versus sequential high-dose-rate intracavitary brachytherapy with external beam radiotherapy in locally advanced carcinoma cervix.
    Alam N; Akram M; Siddiqui SA; Hussain MAB
    J Cancer Res Ther; 2019; 15(6):1254-1259. PubMed ID: 31898656
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study.
    Del Mistro A; Giorgi Rossi P; Frayle H; Pasquale L; Campari C; Ronco G; Zorzi M
    BJOG; 2019 Oct; 126(11):1365-1371. PubMed ID: 31356722
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.
    Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables.
    Gadducci A; Guerrieri ME; Cosio S
    Crit Rev Oncol Hematol; 2019 Mar; 135():103-114. PubMed ID: 30819439
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Is SBRT Boost Feasible for PET Positive Lymph Nodes for cervical cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
    Snyder JE; Willett AB; Sun W; Kim Y
    Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
    Oštrbenk A; Xu L; Arbyn M; Poljak M
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30209184
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Impact of Practice Facilitation in Primary Care on Chronic Disease Care Processes and outcomes: a Systematic Review.
    Wang A; Pollack T; Kadziel LA; Ross SM; McHugh M; Jordan N; Kho AN
    J Gen Intern Med; 2018 Nov; 33(11):1968-1977. PubMed ID: 30066117
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.